1. Home
  2. NURO vs PRPH Comparison

NURO vs PRPH Comparison

Compare NURO & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NURO
  • PRPH
  • Stock Information
  • Founded
  • NURO 1996
  • PRPH 1989
  • Country
  • NURO United States
  • PRPH United States
  • Employees
  • NURO N/A
  • PRPH N/A
  • Industry
  • NURO Medical/Dental Instruments
  • PRPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • NURO Health Care
  • PRPH Health Care
  • Exchange
  • NURO Nasdaq
  • PRPH Nasdaq
  • Market Cap
  • NURO N/A
  • PRPH 10.7M
  • IPO Year
  • NURO N/A
  • PRPH 1997
  • Fundamental
  • Price
  • NURO $4.34
  • PRPH $0.37
  • Analyst Decision
  • NURO
  • PRPH
  • Analyst Count
  • NURO 0
  • PRPH 0
  • Target Price
  • NURO N/A
  • PRPH N/A
  • AVG Volume (30 Days)
  • NURO 2.7K
  • PRPH 2.4M
  • Earning Date
  • NURO 05-14-2025
  • PRPH 05-08-2025
  • Dividend Yield
  • NURO N/A
  • PRPH N/A
  • EPS Growth
  • NURO N/A
  • PRPH N/A
  • EPS
  • NURO N/A
  • PRPH N/A
  • Revenue
  • NURO $3,032,837.00
  • PRPH $6,770,000.00
  • Revenue This Year
  • NURO N/A
  • PRPH $221.82
  • Revenue Next Year
  • NURO N/A
  • PRPH N/A
  • P/E Ratio
  • NURO N/A
  • PRPH N/A
  • Revenue Growth
  • NURO N/A
  • PRPH N/A
  • 52 Week Low
  • NURO $2.66
  • PRPH $0.22
  • 52 Week High
  • NURO $4.73
  • PRPH $7.48
  • Technical
  • Relative Strength Index (RSI)
  • NURO 45.63
  • PRPH 53.48
  • Support Level
  • NURO $4.28
  • PRPH $0.26
  • Resistance Level
  • NURO $4.43
  • PRPH $0.38
  • Average True Range (ATR)
  • NURO 0.06
  • PRPH 0.06
  • MACD
  • NURO -0.01
  • PRPH 0.01
  • Stochastic Oscillator
  • NURO 42.11
  • PRPH 57.27

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.

Share on Social Networks: